Indralin

DB18220ExperimentalSmall molecule

Indralin: Overview.

Mechanism: Pharmacologically active on Retinoic acid receptor RXR-alpha and Human Retinoid X Receptors (RXRs)
Curator reviewed
Formula / weight: C₂₃H₂₈O₂S · 368.54 g/mol (avg)
Also known as: 2-thiophenecarboxylic acid, 5-((1e)-2-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-propen-1-yl)- · 5-((1e)-2-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-propen-1-yl)-2-thiophenecarboxylic acid · Indraline
Code names: AGN-191659

Resolves to

Compound

Structure

InChIKeyQPAMXNZWXFZISY-SDNWHVSQSA-NSMILESC\C(=C/C1=CC=C(S1)C(O)=O)C1=CC2=C(C=C1C)C(C)(C)CCC2(C)C

Targets

What you can answer from here — as of July 09, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Indralin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.